Institutional investors hold a majority ownership of ACT through the 103.44% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2014, these large investors purchased a net $7.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH (... Bought 196.4 Thousand shares of Actavis PLC
J.O. HAMBRO CAPITAL MANAGEMENT L... Bought 45.4 Thousand shares of Actavis PLC
OLD MUTUAL INVESTMENT MANAGEMENT... Bought 19.7 Thousand shares of Actavis PLC